SCHEMBL32690734

SCHEMBL32690734

COC(=O)c1ccc(CC(=O)Nc2ccc3[nH]c(-c4ccccc4C(F)(F)F)c(O)c(=O)c3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ RORC P51449 4/20 0.44
▸ P2RY12 Q9H244 2/20 0.42
▸ MAPT P10636 3/20 0.41
▸ TP53 P04637 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ PARP14 Q460N5 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CCNB2 O95067 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ MDH2 P40926 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690851 0.93 NPC1 (0.46) NPC1RAB9AKMT2AMEN1MAPK1
SCHEMBL32690666 0.89 RORC (0.43) RORCP2RY12PARP14STK17BSTK17A
SCHEMBL32690681 0.88 GABRA1 (0.44) MAPTTP53RXFP1CCNB2CDK1
SCHEMBL32690787 0.84 PARP14 (0.47) NPC1RAB9AKMT2AMEN1MAPK1
SCHEMBL32690673 0.83 PARP14 (0.46) NPC1RAB9AKMT2AMEN1MAPK1
SCHEMBL32690829 0.82 RORC (0.43) NPC1RAB9AKMT2AMEN1RORC
SCHEMBL32690786 0.82 P2RY12 (0.53) P2RY12LMNASTK17BSTK17A
SCHEMBL32690732 0.81 P2RY12 (0.55) P2RY12KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL32690863 0.81 P2RY12 (0.55) P2RY12KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL32690736 0.81 AR (0.48) NPC1RAB9AKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB NPC1 2232/4885RAB9A 1083/4885KMT2A 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback